Jan Balzarini

This inventor holds 35 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Antiviral Compounds. Top assignees: University College Cardiff Consultants Limited, K.u. Leuven Research & Development, Katholieke Universiteit Leuven. Active years: 1997-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Balzarini. Retrieved from https://idiyas.com/inventor/jan-balzarini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 (Patent Applications = 6)

% Patents Active = 51.4

CIPO Patents = 3

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 548(Granted Patents)

Location History:

Egenhoven, BE (1998)
Haverice, BE (2003)
Leuven, BE (2006 - 2015)
Heverlee, BE (1997 - 2024)

Company Filing History:

8 out of 136

University College Cardiff Consultants Limited

patents

7 out of 84

K.u. Leuven Research & Development

patents

7 out of 631

Katholieke Universiteit Leuven

patents

4. 4 out of 477

Consejo Superior De Investigaciones Cientificas

Nucana Biomed Limited

patents

8. 2 out of 50

Institute of Organic Chemistry and Biochemistry

patents

9. 2 out of 21

Rega Stichting, V.z.w.

patents

10. 2 out of 38

Technische Universitat Braunschweig

patents

11. 2 out of 97

University College Cork

patents

12. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

13. 1 out of 5

Kemin Pharma B.v.b.a.

patents

14. 1 out of 259

Medical Research Council

patents

15. 1 out of 3,693

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

16. 1 out of 9

The University of Ferrara

patents

17. 1 out of 3,578

Toray Industries, Inc.

patents

18. 1 out of 237

Université´ D'aix-Marseille

patents

19. 4 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2024

Loading Chart...

Areas of Expertise:

Phosphoramidate Derivatives

Antiviral Compounds

5-Fluoro-2'-Deoxyuridine

Nucleotide Analogues

Anti-Cancer Agents

Viral Infections

Pyrimidine Nucleosides

Prodrugs

Antiretroviral Agents

Kinetoplastids

Chemical Compounds

Antiviral Therapies

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11925658 - Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancer (2024-03-12),

2. 11559542 - Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer (2023-01-24),

3. 10993957 - Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer (2021-05-04),

4. 10610538 - Pradimicin derivatives for the treatment of diseases caused by kinetoplastids (2020-04-07),

5. 10167302 - Phosphonate nucleosides useful in the treatment of viral diseases (2019-01-01),

6. 10022390 - Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer (2018-07-17),

7. 9822137 - Phosphonucleosides useful in the treatment of viral disorders (2017-11-21),

8. 9655915 - Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer (2017-05-23),

9. 9427447 - Anti-viral pyrimidine nucleoside derivatives (2016-08-30),

10. 9351970 - Anti-viral pyrimidine nucleoside analogues (2016-05-31),

11. 9278958 - Anti-cancer compounds (2016-03-08),

12. 9221866 - Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer (2015-12-29),

13. 8946243 - Compounds and methods for the treatment of viral infection (2015-02-03),

14. 8933053 - Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer (2015-01-13),

15. 8912163 - Compositions for the treatment or prophylaxis of viral infections (2014-12-16),

Title: Jan Balzarini - Pioneering Belgian Inventor

Introduction: Jan Balzarini is a distinguished Belgian inventor known for his groundbreaking contributions to the field of pharmaceuticals and antiviral research.

Latest Patents: Jan Balzarini holds several patents related to novel antiviral compounds and pharmaceutical formulations designed to combat a wide range of viral infections.

Career Highlights: With a career spanning over four decades, Jan Balzarini has held prominent positions in various research institutions and pharmaceutical companies, where he has led numerous successful projects resulting in significant advancements in antiviral therapies.

Collaborations: Throughout his career, Jan Balzarini has collaborated with leading scientists, researchers, and pharmaceutical companies worldwide to further the development of innovative antiviral treatments, establishing himself as a key figure in the global fight against viral diseases.

Conclusion: Jan Balzarini's dedication to scientific excellence and his pioneering work in antiviral research have not only earned him international recognition but have also significantly impacted the field of pharmaceuticals, paving the way for the development of new and improved antiviral therapies.

Profile summary based on public USPTO records.